PIN67 MODELING G-DRG REVENUE WHEN HOSPITALIZATION DURATION FROM CLINICAL TRIALS IS AVAILABLE-THE CASE OF DORIPENEM VERSUS IMIPENEM IN TREATING VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN GERMANY
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72864-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72864-9/fulltext
Title :
PIN67 MODELING G-DRG REVENUE WHEN HOSPITALIZATION DURATION FROM CLINICAL TRIALS IS AVAILABLE-THE CASE OF DORIPENEM VERSUS IMIPENEM IN TREATING VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72864-9&doi=10.1016/S1098-3015(11)72864-9
First page :
A442
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1021